메뉴 건너뛰기




Volumn 97, Issue 23, 2011, Pages 1943-1950

High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIENOPYRIDINE DERIVATIVE;

EID: 80655149140     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2011.225466     Document Type: Article
Times cited : (46)

References (36)
  • 1
    • 0033596281 scopus 로고    scopus 로고
    • Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials
    • LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a metaanalysis of randomized controlled trials. JAMA 1999;282:2340-6. (Pubitemid 30013066)
    • (1999) Journal of the American Medical Association , vol.282 , Issue.24 , pp. 2340-2346
    • LaRosa, J.C.1    He, J.2    Vupputuri, S.3
  • 4
    • 0017384270 scopus 로고
    • High density lipoprotein as a protective factor against coronary heart disease. The Framingham study
    • Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707-14. (Pubitemid 8110784)
    • (1977) American Journal of Medicine , vol.62 , Issue.5 , pp. 707-714
    • Gordon, T.1    Castelli, W.P.2    Hjortland, M.C.3
  • 5
    • 0034680352 scopus 로고    scopus 로고
    • Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: The Prospective Pravastatin Pooling Project
    • Sacks FM, Tonkin AM, Shepherd J, et al. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation 2000;102:1893-900.
    • (2000) Circulation , vol.102 , pp. 1893-1900
    • Sacks, F.M.1    Tonkin, A.M.2    Shepherd, J.3
  • 9
    • 10844259913 scopus 로고    scopus 로고
    • Principles for modeling propensity scores in medical research: A systematic literature review
    • DOI 10.1002/pds.969
    • Weitzen S, Lapane KL, Toledano AY, et al. Principles for modeling propensity scores in medical research: a systematic literature review. Pharmacoepidemiol Drug Saf 2004;13:841-53. (Pubitemid 40003819)
    • (2004) Pharmacoepidemiology and Drug Safety , vol.13 , Issue.12 , pp. 841-853
    • Weitzen, S.1    Lapane, K.L.2    Toledano, A.Y.3    Hume, A.L.4    Mor, V.5
  • 10
    • 3543135271 scopus 로고    scopus 로고
    • Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
    • D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81.
    • (1998) Stat Med , vol.17 , pp. 2265-2281
    • D'Agostino Jr., R.B.1
  • 11
    • 0035044501 scopus 로고    scopus 로고
    • Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: A matched analysis using propensity scores
    • DOI 10.1016/S0895-4356(00)00321-8, PII S0895435600003218
    • Normand ST, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 2001;54:387-98. (Pubitemid 32303462)
    • (2001) Journal of Clinical Epidemiology , vol.54 , Issue.4 , pp. 387-398
    • Normand, S.-L.T.1    Landrum, M.B.2    Guadagnoli, E.3    Ayanian, J.Z.4    Ryan, T.J.5    Cleary, P.D.6    McNeil, B.J.7
  • 12
    • 71649101609 scopus 로고    scopus 로고
    • Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: A combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)
    • Zhao XQ, Krasuski RA, Baer J, et al. Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS). Am J Cardiol 2009;104:1457-64.
    • (2009) Am J Cardiol , vol.104 , pp. 1457-1464
    • Zhao, X.Q.1    Krasuski, R.A.2    Baer, J.3
  • 13
    • 0026514346 scopus 로고
    • Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty
    • Shah PK, Amin J. Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty. Circulation 1992;85:1279-85.
    • (1992) Circulation , vol.85 , pp. 1279-1285
    • Shah, P.K.1    Amin, J.2
  • 14
    • 34547962816 scopus 로고    scopus 로고
    • Predictors of In-stent Restenosis and Patient Outcome After Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
    • DOI 10.1016/j.amjcard.2007.03.097, PII S0002914907010399
    • Sukhija R, Aronow WS, Sureddi R, et al. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus. Am J Cardiol 2007;100:777-80. (Pubitemid 47268266)
    • (2007) American Journal of Cardiology , vol.100 , Issue.5 , pp. 777-780
    • Sukhija, R.1    Aronow, W.S.2    Sureddi, R.3    Aleti, S.4    Molavi, B.5    Sachdeva, R.6    Mehta, J.L.7
  • 15
    • 62849086187 scopus 로고    scopus 로고
    • Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions
    • Ghazzal ZB, Dhawan SS, Sheikh A, et al. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions. Am J Cardiol 2009;103:902-6.
    • (2009) Am J Cardiol , vol.103 , pp. 902-906
    • Ghazzal, Z.B.1    Dhawan, S.S.2    Sheikh, A.3
  • 16
    • 38349179869 scopus 로고    scopus 로고
    • Postprocedural high-density lipoprotein cholesterol predicts carotid stent patency at 1 year
    • Topakian R, Sonnberger M, Nussbaumer K, et al. Postprocedural high-density lipoprotein cholesterol predicts carotid stent patency at 1 year. Eur J Neurol 2008;15:179-84.
    • (2008) Eur J Neurol , vol.15 , pp. 179-184
    • Topakian, R.1    Sonnberger, M.2    Nussbaumer, K.3
  • 17
    • 77649342307 scopus 로고    scopus 로고
    • Statins in prevention of repeat revascularization after percutaneous coronary intervention - A meta-analysis of randomized clinical trials
    • Zhang ZJ, Cheng Q, Jiang GX, et al. Statins in prevention of repeat revascularization after percutaneous coronary intervention - a meta-analysis of randomized clinical trials. Pharmacol Res 2010;61:316-20.
    • (2010) Pharmacol Res , vol.61 , pp. 316-320
    • Zhang, Z.J.1    Cheng, Q.2    Jiang, G.X.3
  • 18
    • 18744373337 scopus 로고    scopus 로고
    • High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: Results from the MIRACL trial
    • DOI 10.1093/eurheartj/ehi186
    • Olsson AG, Schwartz GG, Szarek M, et al. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur Heart J 2005;26:890-6. (Pubitemid 40676569)
    • (2005) European Heart Journal , vol.26 , Issue.9 , pp. 890-896
    • Olsson, A.G.1    Schwartz, G.G.2    Szarek, M.3    Sasiela, W.J.4    Ezekowitz, M.D.5    Ganz, P.6    Oliver, M.F.7    Waters, D.8    Zeiher, A.9
  • 19
    • 26244432388 scopus 로고    scopus 로고
    • Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    • Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
    • (2005) Lancet , vol.366 , pp. 1267-1278
    • Baigent, C.1    Keech, A.2    Kearney, P.M.3
  • 20
    • 0014264541 scopus 로고
    • The plasma lecithins:cholesterol acyltransferase reaction
    • Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res 1968;9:155-67.
    • (1968) J Lipid Res , vol.9 , pp. 155-167
    • Glomset, J.A.1
  • 21
    • 0015829488 scopus 로고
    • Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis
    • Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 1973;180:1332-9.
    • (1973) Science , vol.180 , pp. 1332-1339
    • Ross, R.1    Glomset, J.A.2
  • 22
    • 33745369351 scopus 로고    scopus 로고
    • Endothelial and antithrombotic actions of HDL
    • DOI 10.1161/01.RES.0000225982.01988.93, PII 0000301220060609000005
    • Mineo C, Deguchi H, Griffin JH, et al. Endothelial and antithrombotic actions of HDL. Circ Res 2006;98:1352-64. (Pubitemid 43948059)
    • (2006) Circulation Research , vol.98 , Issue.11 , pp. 1352-1364
    • Mineo, C.1    Deguchi, H.2    Griffin, J.H.3    Shaul, P.W.4
  • 24
    • 1942470461 scopus 로고    scopus 로고
    • High-Density Lipoprotein and Cardiovascular Risk
    • DOI 10.1161/01.CIR.0000126889.97626.B8
    • Toth PP. High-density lipoprotein and cardiovascular risk. Circulation 2004;109:1809-12. (Pubitemid 38509111)
    • (2004) Circulation , vol.109 , Issue.15 , pp. 1809-1812
    • Toth, P.P.1
  • 26
    • 0030070173 scopus 로고    scopus 로고
    • Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study
    • Lamarche B, Després JP, Moorjani S, et al. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study. Atherosclerosis 1996;119:235-45.
    • (1996) Atherosclerosis , vol.119 , pp. 235-245
    • Lamarche, B.1    Després, J.P.2    Moorjani, S.3
  • 27
    • 0026597808 scopus 로고
    • Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment
    • Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992;85:37-45.
    • (1992) Circulation , vol.85 , pp. 37-45
    • Manninen, V.1    Tenkanen, L.2    Koskinen, P.3
  • 28
    • 0035488956 scopus 로고    scopus 로고
    • Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population
    • Wang TD, Chen WJ, Chien KL, et al. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population. Am J Cardiol 2001;88:737-43.
    • (2001) Am J Cardiol , vol.88 , pp. 737-743
    • Wang, T.D.1    Chen, W.J.2    Chien, K.L.3
  • 29
    • 78751640788 scopus 로고    scopus 로고
    • Meta-analysis: Statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk
    • Jafri H, Alsheikh-Ali AA, Karas RH. Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk. Ann Intern Med 2010;153:800-8.
    • (2010) Ann Intern Med , vol.153 , pp. 800-808
    • Jafri, H.1    Alsheikh-Ali, A.A.2    Karas, R.H.3
  • 30
    • 77955712458 scopus 로고    scopus 로고
    • HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: An analysis from the JUPITER trial
    • Ridker PM, Genest J, Boekholdt SM, et al. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet 2010;376:333-9.
    • (2010) Lancet , vol.376 , pp. 333-339
    • Ridker, P.M.1    Genest, J.2    Boekholdt, S.M.3
  • 31
    • 35748972380 scopus 로고    scopus 로고
    • Prevalence of Low High-Density Lipoprotein Cholesterol in Patients With Documented Coronary Heart Disease or Risk Equivalent and Controlled Low-Density Lipoprotein Cholesterol
    • DOI 10.1016/j.amjcard.2007.06.058, PII S0002914907014993
    • Alsheikh-Ali AA, Lin JL, Abourjaily P, et al. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol. Am J Cardiol 2007;100:1499-501. (Pubitemid 350050854)
    • (2007) American Journal of Cardiology , vol.100 , Issue.10 , pp. 1499-1501
    • Alsheikh-Ali, A.A.1    Lin, J.-L.2    Abourjaily, P.3    Ahearn, D.4    Kuvin, J.T.5    Karas, R.H.6
  • 32
    • 72049129430 scopus 로고    scopus 로고
    • Extended-release niacin or ezetimibe and carotid intima-media thickness
    • Taylor AJ, Villines TC, Stanek EJ, et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009;361:2113-22.
    • (2009) N Engl J Med , vol.361 , pp. 2113-2122
    • Taylor, A.J.1    Villines, T.C.2    Stanek, E.J.3
  • 33
    • 33750897238 scopus 로고    scopus 로고
    • Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: A meta-analysis of 23 randomized lipid trials
    • DOI 10.1097/MOL.0b013e32800ff750, PII 0004143320061200000005
    • Brown BG, Stukovsky KH, Zhao XQ. Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials. Curr Opin Lipidol 2006;17:631-6. (Pubitemid 44729955)
    • (2006) Current Opinion in Lipidology , vol.17 , Issue.6 , pp. 631-636
    • Brown, B.G.1    Stukovsky, K.H.2    Zhao, X.-Q.3
  • 34
    • 77953696964 scopus 로고    scopus 로고
    • Individualising the risks of statins in men and women in England and Wales: Population-based cohort study
    • Hippisley-Cox J, Coupland C. Individualising the risks of statins in men and women in England and Wales: population-based cohort study. Heart 2010;96:939-47.
    • (2010) Heart , vol.96 , pp. 939-947
    • Hippisley-Cox, J.1    Coupland, C.2
  • 35
    • 77956109178 scopus 로고    scopus 로고
    • High-density lipoprotein cholesterol increase and non-cardiovascular mortality: A meta-analysis
    • Burillo E, Andres EM, Mateo-Gallego R, et al. High-density lipoprotein cholesterol increase and non-cardiovascular mortality: a meta-analysis. Heart 2010;96:1345-51.
    • (2010) Heart , vol.96 , pp. 1345-1351
    • Burillo, E.1    Andres, E.M.2    Mateo-Gallego, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.